phone

Respiratory Diseases Drugs Market Global Report 2017

  • Published Date: 17 Jul 2017
  • Number of Pages: 125
  • Category: Healthcare and Medical
  • Country: Global

Respiratory Diseases Drugs Market Global Report 2017 Including: Anti-Asthmatics And COPD Drugs Market, Cough And Cold Preparations, Covering: GlaxosmithKline, Novartis AG, Pfizer Inc., Boehringer Ingelheim, and AstraZeneca PLC
 
 Top competitors in the respiratory diseases drugs market are strategically partnering and collaborating with other companies to broaden their product portfolio is a major trend in this market. For instance, in March 2017, AstraZeneca announced collaboration with Circassia Pharmaceuticals plc, (a UK based respiratory biopharmaceutical company) for the development and commercialisation of Tudorza and Duaklir in the US. Tudorza and Duaklir are used in the treatment of chronic obstructive pulmonary disease (COPD).
 
 The Respiratory Diseases Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global respiratory diseases drugs sector.
 
 <b>Reasons to Purchase</b>
 
 • Outperform competitors using accurate up to date demand-side dynamics information.
 • Identify growth segments for investment.
 • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
 • Create regional and country strategies on the basis of local data and analysis.
 • Stay abreast of the latest customer and market research findings
 • Benchmark performance against key competitors.
 • Develop strategies based on likely future developments.
 • Utilize the relationships between key data sets for superior strategizing.
 • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
 • Gain a global perspective on the development of the market.
 • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
 
 <b>Description: </b>
 
 Where is the largest and fastest growing market for the respiratory diseases drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory diseases drugs market global report from the Business Research Company answers all these questions and many more.
 
 The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
 
 • The market characteristics section of the report defines and explains the market.
 • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
 • Market segmentations break down market into sub markets.
 • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
 • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
 • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
 • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.
 • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
 
 <b>Scope</b>
 
 Markets Covered: Anti-Asthma And COPD Products Market, Cough And Cold Preparations
 
 Companies Mentioned: GlaxosmithKline, Novartis AG, Pfizer Inc., Boehringer Ingelheim, and AstraZeneca PLC
 
 Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
 
 Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
 
 Time series: Five years historic and forecast.
 
 Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.
 
 Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
 
 Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  

Publisher Name : The Business Research Company

1. Respiratory Diseases Drugs Market Characteristics;

2. Respiratory Diseases Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Respiratory Diseases Drugs Market Customer Information;

5. Respiratory Diseases Drugs Market Segmentation;
5.1. Global Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 5.2. Global Respiratory Diseases Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Respiratory Diseases Drugs Market Trends And Strategies;

6. Respiratory Diseases Drugs Market Regional And Country Analysis;
6.1. Global Respiratory Diseases Drugs Market, 2016, By Region; 6.2. Global Respiratory Diseases Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Respiratory Diseases Drugs Market, 2016, By Country; 6.4. Respiratory Diseases Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors;
7.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Respiratory Diseases Drugs Expenditure, Global;

8. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Respiratory Diseases Drugs Expenditure, By Country;

9. Respiratory Diseases Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Respiratory Diseases Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Respiratory Diseases Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Respiratory Diseases Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Respiratory Diseases Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Asthma, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Respiratory Diseases Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Respiratory Diseases Drugs Market;
10.1.1. Asia-Pacific Respiratory Diseases Drugs Market Overview; 10.1.2. Asia-Pacific Respiratory Diseases Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 10.2. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis; 10.3. China Respiratory Diseases Drugs Market; 10.3.1. China Respiratory Diseases Drugs Market Overview; 10.3.2. China Respiratory Diseases Drugs Historic Market, 2012 - 2016; 10.3.3. China Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 10.3.4. China Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 10.3.5. China Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 10.4. India Respiratory Diseases Drugs Market; 10.4.1. India Respiratory Diseases Drugs Market Overview; 10.4.2. India Respiratory Diseases Drugs Historic Market, 2012 - 2016; 10.4.3. India Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 10.4.4. India Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 10.4.5. India Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 10.5. Japan Respiratory Diseases Drugs Market; 10.5.1. Japan Respiratory Diseases Drugs Market Overview; 10.5.2. Japan Respiratory Diseases Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 10.5.5. Japan Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 10.6. Australia Respiratory Diseases Drugs Market; 10.6.1. Australia Respiratory Diseases Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 10.6.4. Australia Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020;

11. Western Europe Respiratory Diseases Drugs Market;
11.1.1. Western Europe Respiratory Diseases Drugs Market Overview; 11.1.2. Western Europe Respiratory Diseases Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 11.2. Western Europe Respiratory Diseases Drugs Market: Country Analysis; 11.3. UK Respiratory Diseases Drugs Market; 11.3.1. UK Respiratory Diseases Drugs Market Overview; 11.3.2. UK Respiratory Diseases Drugs Historic Market, 2012 - 2016; 11.3.3. UK Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 11.3.5. UK Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 11.4. Germany Respiratory Diseases Drugs Market; 11.4.1. Germany Respiratory Diseases Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 11.4.4 Germany Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 11.5 France Respiratory Diseases Drugs Market; 11.5.1 France Respiratory Diseases Drugs Historic Market, 2012 - 2016; 11.5.2 France Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 11.5.3 France Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 11.5.4 France Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 11.6. Italy Respiratory Diseases Drugs Market; 11.6.1. Italy Respiratory Diseases Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 11.6.4. Italy Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020; 11.7. Spain Respiratory Diseases Drugs Market; 11.7.1. Spain Respiratory Diseases Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 11.7.4. Spain Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020;

12. Eastern Europe Respiratory Diseases Drugs Market;
12.1.1. Eastern Europe Respiratory Diseases Drugs Market Overview; 12.1.2. Eastern Europe Respiratory Diseases Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 12.2. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis; 12.3. Russia Respiratory Diseases Drugs Market; 12.3.1. Russia Respiratory Diseases Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 12.3.4. Russia Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020;

13. North America Respiratory Diseases Drugs Market;
13.1.1. North America Respiratory Diseases Drugs Market Overview; 13.1.2. North America Respiratory Diseases Drugs Historic Market, 2012 - 2016; 13.1.3. North America Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 13.2. North America Respiratory Diseases Drugs Market: Country Analysis; 13.3. USA Respiratory Diseases Drugs Market; 13.3.1. USA Respiratory Diseases Drugs Historic Market, 2012 - 2016; 13.3.2. USA Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 13.3.4. USA Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020;

14. South America Respiratory Diseases Drugs Market;
14.1.1. South America Respiratory Diseases Drugs Market Overview; 14.1.2. South America Respiratory Diseases Drugs Historic Market, 2012 - 2016; 14.1.3. South America Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 14.2. South America Respiratory Diseases Drugs Market: Country Analysis; 14.3. Brazil Respiratory Diseases Drugs Market; 14.3.1. Brazil Respiratory Diseases Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations; 14.3.4. Brazil Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020;

15. Middle East Respiratory Diseases Drugs Market;

15.1.1. Middle East Respiratory Diseases Drugs Market Overview; 15.1.2. Middle East Respiratory Diseases Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations;

16. Africa Respiratory Diseases Drugs Market;
16.1.1. Africa Respiratory Diseases Drugs Market Overview; 16.1.2. Africa Respiratory Diseases Drugs Historic Market, 2012 - 2016; 16.1.2. Africa Respiratory Diseases Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Respiratory Diseases Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Respiratory Diseases Drugs Market, 2016, By Segment; Anti-Asthmatics And COPD Drugs Market; Cough And Cold Preparations;

17. Respiratory Diseases Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. GlaxoSmithKline; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Pfizer Inc.; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Boehringer Ingelheim; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Astrazeneca Plc; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer



The global anesthesia and respiratory devices market is segmented into respiratory devices and anesthesia devices. Anesthesia devices are used to support the administration of anesthetics and medical gases such as

View Report

The global respiratory disposables market was estimated to be around $1.5 billion as of 2016. The global respiratory disposables made up around 9% of the overall anesthesia and respiratory devices

View Report

Respiratory devices (therapeutic and diagnostic) market comprises of diagnostic devices for measuring the volume of air inspired and expired by the lungs; Polysomnography (a sleep study to check respiration rate);

View Report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports